Personal information

Other IDs

Scopus Author ID: 13609839000
ResearcherID: O-5145-2019

Keywords

Structural biology, viral fusion

Countries

France

Activities

Collapse all

Employment (3)

Institut Pasteur: Paris, Ile de France, FR

2015-06-01 to present | Staff Scientist (Chargé de Recherche) (Virologie)
Employment
Source: Self-asserted source
Pablo Guardado Calvo

Institut Pasteur: Paris, Île-de-France, FR

2010-05-01 to 2015-05-31 | Postdoctoral Fellow (Virologie)
Employment
Source: Self-asserted source
Pablo Guardado Calvo

Universidad de Santiago de Compostela: Santiago de Compostela, Galicia, ES

2004-06-01 to 2010-04-31 | Predoctoral Fellow (Biochemistry)
Employment
Source: Self-asserted source
Pablo Guardado Calvo

Education and qualifications (2)

Université Paris Descartes: Paris, Île-de-France, FR

2019-09-16 to present | Habilitation à Diriger Recherches (HDR)
Education
Source: Self-asserted source
Pablo Guardado Calvo

University of Santiago de Compostela: Santiago de Compostela, ES

2004-06 to 2010-04 | PhD. Structural Biology (Biochemistry)
Education
Source: Self-asserted source
Pablo Guardado Calvo

Funding (2)

Structural basis of lipid sensing in viral fusion

2019-03 to 2022-03 | Grant
Agence Nationale de la Recherche (Paris, FR)
GRANT_NUMBER: ANR-18-CE11-0011
Source: Self-asserted source
Pablo Guardado Calvo

Structural vaccinology in Bunyaviruses

2016-12 to 2019-12 | Grant
ANR-IBEID (Paris, FR)
GRANT_NUMBER:

ANR-10-LABX-62-IBEID 4E AAP
Source: Self-asserted source
Pablo Guardado Calvo

Peer review (36 reviews for 12 publications/grants)

Review activity for Advanced science. (1)
Review activity for EMBO journal. (1)
Review activity for FEBS open bio. (2)
Review activity for International journal of molecular sciences. (5)
Review activity for Journal of general virology. (1)
Review activity for Journal of virology : (1)
Review activity for Nature (1)
Review activity for Nature communications (5)
Review activity for Nature microbiology. (4)
Review activity for PLOS pathogens : (3)
Review activity for Vaccines. (3)
Review activity for Viruses. (9)
How many people are using ORCID?